I was once chatting with someone being business development at Sanofi. According to him they took 1 1⁄2 years to exchange a button on their website because their internal processes are filled with bureaucracy.
From that perspective there’s the justified belief that big pharma has no capacity to develop new technology of this kind inhouse. They could hire a bunch of AI Phds but they likely would drown them in bureaucracy so that they wouldn’t get the kind of results that AlphaFold got. It’s much easier to let someone else do the work and then license it.
I was once chatting with someone being business development at Sanofi. According to him they took 1 1⁄2 years to exchange a button on their website because their internal processes are filled with bureaucracy.
From that perspective there’s the justified belief that big pharma has no capacity to develop new technology of this kind inhouse. They could hire a bunch of AI Phds but they likely would drown them in bureaucracy so that they wouldn’t get the kind of results that AlphaFold got. It’s much easier to let someone else do the work and then license it.
Exactly. Machine learning is not pharma’s comparative advantage.